Impact of COVID-19 on patient enrolment to commercial clinical trials globally: by disease area

Scientist in the background, with huge stainless steel vats in the foreground
Enrolment commercial oncology studies month relative to 2019 baseline, country (January 2020-July 2021)

title-strip icon Enrolment commercial oncology studies month relative to 2019 baseline, country (January 2020-July 2021)

Enrolment commercial cardio-metabolic studies month relative to 2019 baseline, country (January 2020-July 2021)

title-strip icon Enrolment commercial cardio-metabolic studies month relative to 2019 baseline, country (January 2020-July 2021)

Enrolment commercial nervous studies month relative to 2019 baseline, country (January 2020-July 2021)

title-strip icon Enrolment commercial nervous studies month relative to 2019 baseline, country (January 2020-July 2021)

Enrolment commercial immune studies month relative to 2019 baseline, country (January 2020-July 2021)

title-strip icon Enrolment commercial immune studies month relative to 2019 baseline, country (January 2020-July 2021)

Enrolment for commercial infectious studies month relative to 2019 baseline, country (January 2020-July 2021)

title-strip icon Enrolment for commercial infectious studies month relative to 2019 baseline, country (January 2020-July 2021)